Skip to main content
. Author manuscript; available in PMC: 2016 Dec 10.
Published in final edited form as: ACS Infect Dis. 2016 Oct 4;2(12):945–957. doi: 10.1021/acsinfecdis.6b00144

Figure 6.

Figure 6

Oral (PO) and intravenous (IV) pharmacokinetic profiles after a single dose of DSM421 in A) mice, B) rats and C) dogs. Dose levels are indicated on the graph. Data represent the mean ± range of n=2 samples per time point for mice and n= 2 rats, or mean ± SD for n=3 dogs. Dosing conditions are described in Table S14.